R. H. Ahmed, H. Z. Huri, S. Muniandy, Z. Al-hamodi, B. Al-absi et al., Altered circulating concentrations of active glucagonlike peptide (GLP-1) and dipeptidyl peptidase 4 (DPP4) in obese subjects and their association with insulin resistance, Clin. Biochem, vol.50, pp.746-749, 2017.

R. Anastasiou, M. Papadelli, M. D. Georgalaki, G. Kalantzopoulos, and E. Tsakalidou, Cloning and sequencing of the gene encoding X-prolyl-dipeptidyl aminopeptidase (PepX) from Streptococcus thermophilus strain ACA-DC 4, J. Appl. Microbiol, vol.93, pp.52-59, 2002.

R. H. Anderberg, J. E. Richard, C. Hansson, H. Nissbrandt, F. Bergquist et al., GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionality, Psychoneuroendocrinology, vol.65, pp.54-66, 2016.

T. Bansal, R. C. Alaniz, T. K. Wood, J. , and A. , The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation, Proc. Natl. Acad. Sci. U.S.A, vol.107, pp.228-233, 2010.

F. Blachier, F. Mariotti, J. F. Huneau, and D. Tomé, Effects of amino acidderived luminal metabolites on the colonic epithelium and physiopathological consequences, Amino Acids, vol.33, pp.547-562, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01186779

J. Breton, N. Tennoune, N. Lucas, M. Francois, R. Legrand et al., Gut commensal, E. coli proteins activate host satiety pathways following nutrient-induced bacterial growth, Cell Metab, vol.23, pp.324-358, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01397996

A. Caminero, H. J. Galipeau, J. L. Mccarville, C. W. Johnston, S. P. Bernier et al., Duodenal bacteria from patients with celiac disease and healthy subjects distinctly affect gluten breakdown and immunogenicity, Gastroenterology, vol.151, pp.670-683, 2016.

P. D. Cani, Gut microbiota-at the intersection of everything?, Nat. Rev. Gastroenterol. Hepatol, vol.14, pp.321-322, 2017.

P. D. Cani, A. M. Neyrinck, N. Maton, and N. M. Delzenne, Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1, Obes. Res, vol.13, pp.1000-1007, 2005.

F. Canneva, Y. Golub, J. Distler, J. Dobner, S. Meyer et al., DPP4-deficient congenic rats display blunted stress, improved fear extinction and increased central NPY, Psychoneuroendocrinology, vol.53, pp.195-206, 2015.

S. L. Conarello, Z. Li, J. Ronan, R. S. Roy, L. Zhu et al., Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance, Proc. Natl. Acad. Sci. U.S.A, vol.100, pp.6825-6830, 2003.

K. G. Cooper and J. P. Woods, Secreted dipeptidyl peptidase IV activity in the dimorphic fungal pathogen Histoplasma capsulatum, Infect. Immun, vol.77, pp.2447-2454, 2009.

O. J. Cordero, F. J. Salgado, and M. Nogueira, On the origin of serum CD26 and its altered concentration in cancer patients, Cancer Immunol. Immunother, vol.58, pp.1723-1747, 2009.

H. M. Cox, Peptide YY: a neuroendocrine neighbor of note, Peptides, vol.28, pp.345-351, 2007.

J. Cuenco, J. Minnion, T. Tan, R. Scott, N. Germain et al., Degradation paradigm of the gut hormone, pancreatic polypeptide, by hepatic and renal peptidases, Endocrinology, vol.158, pp.1755-1765, 2017.

M. De-angelis, A. Cassone, C. G. Rizzello, F. Gagliardi, F. Minervini et al., Mechanism of degradation of immunogenic gluten epitopes from Triticum turgidum L. var. durum by sourdough lactobacilli and fungal proteases, Appl. Environ. Microbiol, vol.76, pp.508-526, 2010.

N. M. Delzenne and L. B. Bindels, Gut microbiota in 2017: Contribution of gut microbiota-host cooperation to drug efficacy, Nat. Rev. Gastroenterol. Hepatol, vol.15, pp.69-70, 2018.

N. M. Delzenne, P. D. Cani, A. Everard, A. M. Neyrinck, and L. B. Bindels, Gut microorganisms as promising targets for the management of type 2 diabetes, Diabetologia, vol.58, pp.2206-2217, 2015.

N. M. Delzenne, A. M. Neyrinck, F. Bäckhed, and P. D. Cani, Targeting gut microbiota in obesity: effects of prebiotics and probiotics, Nat. Rev. Endocrinol, vol.7, pp.639-646, 2011.

D. Detel, M. Persic, and J. Varljen, Serum and intestinal dipeptidyl peptidase IV (DPP IV/CD26) activity in children with celiac disease, J. Pediatr. Gastroenterol. Nutr, vol.45, pp.65-70, 2007.

D. Detel, E. P. Pugel, L. B. Pucar, S. Buljevic, and J. Varljen, Development and resolution of colitis in mice with target deletion of dipeptidyl peptidase IV, Exp. Physiol, vol.97, pp.486-496, 2012.

T. T. Do, P. Hindlet, A. J. Waligora-dupriet, N. Kapel, N. Neveux et al., Disturbed intestinal nitrogen homeostasis in a mouse model of high-fat diet-induced obesity and glucose intolerance, Am. J. Physiol. Endocrinol. Metab, vol.306, 2014.

M. El-yacoubi, J. M. Vaugeois, D. Marguet, N. Sauze, R. Guieu et al., Behavioral characterization of CD26 deficient mice in animal tests of anxiety and antidepressant-like activity, Behav. Brain Res, vol.171, pp.279-285, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00135369

S. Elgun, A. Keskinege, and H. Kumbasar, Dipeptidyl peptidase IV and adenosine deaminase activity. Decrease in depression, Psychoneuroendocrinology, vol.24, pp.823-855, 1999.

A. Everard and P. D. Cani, Gut microbiota and GLP-1, Rev. Endocr. Metab. Disord, vol.15, pp.189-196, 2014.

D. Fteita, E. Könönen, M. Gürsoy, E. Söderling, and U. K. Gursoy, Does estradiol have an impact on the dipeptidyl peptidase IV enzyme activity of the Prevotella intermedia group bacteria?, Anaerobe, vol.36, pp.14-18, 2015.

D. Fteita, A. A. Musrati, E. Kononen, X. Ma, M. Gursoy et al., Dipeptidyl peptidase IV and quorum sensing signaling in biofilm-related virulence of Prevotella aurantiaca, Anaerobe, vol.48, pp.152-159, 2017.

M. Gatti, J. De-dea-lindner, F. Gardini, G. Mucchetti, D. Bevacqua et al., A model to assess lactic acid bacteria aminopeptidase activities in Parmigiano Reggiano cheese during ripening, J. Dairy Sci, vol.91, pp.4129-4137, 2008.

M. S. Geier, D. Tenikoff, R. Yazbeck, G. W. Mccaughan, C. A. Abbott et al., Development and resolution of experimental colitis in mice with targeted deletion of dipeptidyl peptidase IV, J. Cell. Physiol, vol.204, pp.687-692, 2005.

P. Glaser, C. Rusniok, C. Buchrieser, F. Chevalier, L. Frangeul et al., Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease, Mol. Microbiol, vol.45, pp.1499-1513, 2002.

J. M. Goldstein, A. Banbula, T. Kordula, J. A. Mayo, T. et al., Novel extracellular x-prolyl dipeptidyl-peptidase (DPP) from Streptococcus gordonii FSS2: an emerging subfamily of viridans Streptococcal x-prolyl DPPs, Infect. Immun, vol.69, pp.5494-5501, 2001.

M. D. Gorrell, V. Gysbers, and G. W. Mccaughan, CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes, Scand. J. Immunol, vol.54, pp.249-264, 2001.

R. Guieu, E. Fenouillet, C. Devaux, Z. Fajloun, L. Carrega et al., CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity, Behav. Brain Res, vol.166, pp.230-235, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00080809

A. M. Hassan, P. Jain, R. Mayerhofer, E. E. Fröhlich, A. Farzi et al., Visceral hyperalgesia caused by peptide YY deletion and Y2 receptor antagonism, Sci. Rep, vol.7, p.40968, 2017.

P. M. Hellström, J. Hein, P. Bytzer, E. Bjornsson, J. Kristensen et al., Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study, Aliment. Pharmacol. Ther, vol.29, pp.198-206, 2009.

M. Hildebrandt, M. Rose, J. Ruter, A. Salama, H. Monnikes et al., Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease, Scand. J. Gastroenterol, vol.36, pp.1067-1072, 2001.

P. Holzer, F. Reichmann, and A. Farzi, Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis, Neuropeptides, vol.46, pp.261-274, 2012.

V. K. Hopsu-havu and G. G. Glenner, A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide, Histochemie, vol.7, pp.197-201, 1966.

R. Isacson, E. Nielsen, K. Dannaeus, G. Bertilsson, C. Patrone et al., The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test, Eur. J. Pharmacol, vol.650, pp.249-255, 2011.

M. Kamble, R. Gupta, H. S. Rehan, and L. K. Gupta, Neurobehavioral effects of liraglutide and sitagliptin in experimental models, Eur. J. Pharmacol, vol.774, pp.64-70, 2016.

T. Karagiannis, P. Paschos, K. Paletas, D. R. Matthews, and A. Tsapas, Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis, BMJ, vol.344, p.1369, 2012.

C. Klemann, L. Wagner, M. Stephan, and S. Von-hörsten, Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system, Clin. Exp. Immunol, vol.185, pp.1-21, 2016.

H. Kozakova, J. Kolinska, Z. Lojda, Z. Rehakova, J. Sinkora et al., Effect of bacterial monoassociation on brush-border enzyme activities in ex-germ-free piglets: comparison of commensal and pathogenic Escherichia coli strains, Microbes Infect, vol.8, pp.2629-2639, 2006.

H. Kozáková, Z. Reháková, and J. Kolínská, Bifidobacterium bifidum monoassociation of gnotobiotic mice: effect on enterocyte brush-border enzymes, Folia Microbiol, vol.46, pp.573-576, 2001.

H. Kozáková, R. Stepánková, Z. Reháková, and J. Kolínská, Differences in enterocyte brush border enzyme activities in ageing rats reared in germ-free and conventional conditions, Physiol. Res, vol.47, pp.253-258, 1998.

J. M. Laparra and Y. Sanz, Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion, J. Cell. Biochem, vol.109, pp.801-807, 2010.

Y. Lin, K. Krogh-andersen, J. Pelletier, H. Marcotte, C. G. Östenson et al., Oral delivery of pentameric glucagon-like peptide-1 by recombinant Lactobacillus in diabetic rats, PLoS ONE, vol.11, p.162733, 2016.

M. Ma, Y. Hasegawa, N. Koibuchi, K. Toyama, K. Uekawa et al., DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice, Cardiovasc. Diabetol, vol.14, p.54, 2015.

Y. M. Magdy, O. A. El-kharashi, E. S. Nabih, S. M. Shaker, L. F. Abd-elaziz et al., Potential involvement of JNK1 repression in the hepatic effect of sitagliptin and metformin in rats subjected to high fat diet and chronic mild distress, Biomed. Pharmacother, vol.85, pp.225-238, 2017.

D. Marguet, L. Baggio, T. Kobayashi, A. M. Bernard, M. Pierres et al., Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26, Proc. Natl. Acad. Sci. U.S.A, vol.97, pp.6874-6879, 2000.

A. Mascolo, C. Rafaniello, L. Sportiello, M. Sessa, D. Cimmaruta et al., Dipeptidyl peptidase (DPP)-4 Inhibitor-Induced Arthritis/Arthralgia: a review of clinical cases, Drug Saf, vol.39, pp.401-407, 2016.

J. Matos, M. Nardi, H. Kumura, and V. Monnet, Genetic characterization of pepP, which encodes an aminopeptidase P whose deficiency does not affect Lactococcus lactis growth in milk, unlike deficiency of the X-prolyl dipeptidyl aminopeptidase, Appl. Environ. Microbiol, vol.64, pp.4591-4595, 1998.

S. Mimura, T. Ando, K. Ishiguro, O. Maeda, O. Watanabe et al., Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis, Scand. J. Gastroenterol, vol.48, pp.1152-1159, 2013.

G. W. Moran, C. O'neill, P. Padfield, and J. T. Mclaughlin, Dipeptidyl peptidase-4 expression is reduced in Crohn's disease, Regul. Pept, vol.177, pp.40-45, 2012.

C. D. Moulton, J. C. Pickup, S. A. Amiel, K. Winkley, and K. Ismail, Investigating incretin-based therapies as a novel treatment for depression in type 2 diabetes: findings from the South London Diabetes (SOUL-D) Study, Prim. Care Diabetes, vol.10, pp.156-159, 2016.

E. E. Mulvihill, E. M. Varin, B. Gladanac, J. E. Campbell, J. R. Ussher et al., Cellular sites and mechanisms linking reduction of dipeptidyl peptidase-4 activity to control of incretin hormone action and glucose homeostasis, Cell Metab, vol.25, pp.152-165, 2017.

P. Naveilhan, H. Hassani, G. Lucas, K. H. Blakeman, J. X. Hao et al., Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptor, Nature, vol.409, pp.513-517, 2001.

T. Nozu, S. Miyagishi, S. Kumei, R. Nozu, K. Takakusaki et al., Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats, J. Gastroenterol. Hepatol, vol.33, pp.232-239, 2018.

M. Olivares, A. M. Neyrinck, S. A. Pötgens, M. Beaumont, N. Salazar et al., The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice, Diabetologia, vol.61, pp.1838-1848, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02620653

H. K. Pedersen, V. Gudmundsdottir, H. B. Nielsen, T. Hyotylainen, T. Nielsen et al., Human gut microbes impact host serum metabolome and insulin sensitivity, Nature, vol.535, pp.376-381, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01594855

N. D. Rawlings, A. J. Barrett, and R. Finn, Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors, Nucleic Acids Res, vol.44, 2016.

J. P. Redrobe, Y. Dumont, A. Fournier, and R. Quirion, The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test, Neuropsychopharmacology, vol.26, pp.615-624, 2002.

P. Rigolet, X. G. Xi, S. Rety, and J. F. Chich, The structural comparison of the bacterial PepX and human DPP-IV reveals sites for the design of inhibitors of PepX activity, FEBS J, vol.272, pp.2050-2059, 2005.
URL : https://hal.archives-ouvertes.fr/hal-02396438

J. Rosmaninho-salgado, A. P. Marques, M. Estrada, M. Santana, V. Cortez et al., Dipeptidyl-peptidase-IV by cleaving neuropeptide Y induces lipid accumulation and PPAR-gamma expression, Peptides, vol.37, pp.49-54, 2012.

M. Salaga, A. Mokrowiecka, M. Zielinska, E. Malecka-panas, R. Kordek et al., New peptide inhibitor of dipeptidyl peptidase, I. V., EMDB-1 extends the half-life of GLP-2 and attenuates colitis in mice after topical administration, J. Pharmacol. Exp. Ther, vol.363, pp.92-103, 2017.

Y. Sanz and F. Toldra, Purification and characterization of an X-prolyldipeptidyl peptidase from Lactobacillus sakei, Appl. Environ. Microbiol, vol.67, 2001.

Y. Seino, M. Fukushima, and D. Yabe, GIP and GLP-1, the two incretin hormones: similarities and differences, J. Diabetes Investig, vol.1, pp.8-23, 2010.

L. Shan, S. W. Qiao, H. Arentz-hansen, Ø. Molberg, G. M. Gray et al., Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue, J. Proteome Res, vol.4, pp.1732-1741, 2005.

R. P. Shannon, DPP-4 inhibition and neuroprotection: do mechanisms matter?, Diabetes, vol.62, pp.1029-1031, 2013.

Y. Shibata, Y. Miwa, K. Hirai, and S. Fujimura, Purification and partial characterization of a dipeptidyl peptidase from Prevotella intermedia, Oral Microbiol. Immunol, vol.18, pp.196-198, 2003.

F. Sommer and F. Bäckhed, The gut microbiota-masters of host development and physiology, Nat. Rev. Microbiol, vol.11, pp.227-238, 2013.

A. Stengel, M. Goebel-stengel, P. Teuffel, T. Hofmann, P. Buße et al., Obese patients have higher circulating protein levels of dipeptidyl peptidase IV, Peptides, vol.61, pp.75-82, 2014.

A. K. Sterkel, J. L. Lorenzini, J. S. Fites, K. Subramanian-vignesh, T. D. Sullivan et al., Fungal mimicry of a mammalian aminopeptidase disables innate immunity and promotes pathogenicity, Cell Host Microbe, vol.19, pp.361-374, 2016.

T. Stressler, T. Eisele, M. Schlayer, S. Lutz-wahl, and L. Fischer, Characterization of the recombinant exopeptidases PepX and PepN from Lactobacillus helveticus ATCC 12046 important for food protein hydrolysis, PLoS ONE, vol.8, p.70055, 2013.

Ö. Üstün-aytekin, S. Arisoy, A. Aytekin, Ö. Yildiz, and E. , Statistical optimization of cell disruption techniques for releasing intracellular Xprolyl dipeptidyl aminopeptidase from Lactococcus lactis spp. lactis, Ultrason Sonochem, vol.29, pp.163-71, 2016.

P. Varmanen, K. Savijoki, S. Avall, A. Palva, and S. Tynkkynen, X-prolyl dipeptidyl aminopeptidase gene (pepX) is part of the glnRA operon in Lactobacillus rhamnosus, J. Bacteriol, vol.182, pp.146-154, 2000.

N. D. Walker, N. R. Mcewan, and R. J. Wallace, Cloning and functional expression of dipeptidyl peptidase IV from the ruminal bacterium Prevotella albensis M384(T), Microbiology, vol.149, pp.2227-2234, 2003.

R. J. Wallace, N. Mckain, G. A. Broderick, L. M. Rode, N. D. Walker et al., Peptidases of the rumen bacterium, Prevotella ruminicola, Anaerobe, vol.3, pp.35-42, 1997.

Z. Wang, X. Zeng, Y. Mo, K. Smith, Y. Guo et al., Identification and characterization of a bile salt hydrolase from Lactobacillus salivarius for development of novel alternatives to antibiotic growth promoters, Appl. Environ. Microbiol, vol.78, pp.8795-8802, 2012.

J. Zhong, Q. Gong, A. Goud, S. Srinivasamaharaj, and S. Rajagopalan, Recent advances in dipeptidyl-peptidase-4 inhibition therapy: lessons from the bench and clinical trials, J. Diabetes Res, p.606031, 2015.